[1] Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 1986, 46(5): 705-716.[2] Grilli M, Chiu JJS, Lenardo MJ. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol, 1993, 143: 1-62.[3] Kopp EB, Ghosh S. NF-κB and Rel proteins in innate immunity. Adv Immunol, 1995, 58: 1-27.[4] Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev, 1995, 9(22): 2723-2735.[5] Huxford T, Huang DB, Malek S, Ghosh G. The crystal structure of the IκBα/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell, 1998, 95(6): 759-770.[6] Jacobs MD, Harrison SC. Structure of an IκBα/NF-κB complex. Cell, 1998, 95(6): 749 -758.[7] Chen FE, Huang DB, Chen YQ, Ghosh G. Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA. Nature, 1998, 391(6665): 410-413.[8] Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene, 1999, 18(49): 6853-6866.[9] Lim CA, Yao F, Wong JJY, George J, Xu H, Chiu KP, Sung WK, Lipovich L, Vega VB, Chen J, Shahab A, Zhao XD, Hibberd M, Wei CL, Lim B, Ng HH, Ruan YJ, Chin KC. Genome-wide mapping of RELA (p65) binding identifies E2F1 as a transcriptional activator recruited by NF-κB upon TLR4 activation. Mol Cell, 2007, 27(4): 622-635.[10] Giorgetti L, Siggers T, Tiana G, Caprara G, Notarbartolo S, Corona T, Pasparakis M, Milani P, Bulyk ML, Natoli G. Noncooperative interactions between transcription factors and clustered DNA binding sites enable graded transcriptional responses to environmental inputs. Mol Cell, 2010, 37(3): 418-428.[11] Bunting K, Rao S, Hardy K, Woltring D, Denyer GS, Wang J, Gerondakis S, Shannon MF. Genome- wide analysis of gene expression in T cells to identify targets of the NF-κB transcription factor c-Rel. J Immunol, 2007, 178(11): 7097-7109.[12] Tian B, Nowak DE, Jamaluddin M, Wang SF, Brasier AR. Identification of direct genomic targets downstream of the nuclear factor-κB transcription factor mediating tumor necrosis factor signaling. J Biol Chem, 2005, 280(17): 17435-17448.[13] Kasowski M, Grubert F, Heffelfinger C, Hariharan M, Asabere A, Waszak SM, Habegger L, Rozowsky J, Shi M, Urban AE, Hong MY, Karczewski KJ, Huber W, Weissman SM, Gerstein MB, Korbel JO, Snyder M. Variation in transcription factor binding among humans. Science, 2010, 328(5975): 232-235.[14] Caamano J, Hunter CA. NF-κB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev, 2002, 15(3): 414-429.[15] Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J Clin Invest, 2001, 107(1): 7-11.[16] Rayet B, Gélinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene, 1999, 18(49): 6938-6947.[17] Ghosh S, May MJ, Kopp EB. NF-κB and rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol, 1998, 16(1): 225-260.[18] Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW, Yamamoto N. Constitutive activation of NF-κB in primary adult T-cell leukemia cells. Blood, 1999, 93(7): 2360- 2368.[19] Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dorken B. Constitutive nuclear factor-κB- RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest, 1997, 100(12): 2961-2969.[20] Wood LD, Richmond A. Constitutive and cytokine- induced expression of the melanoma growth stimulatory activity/GROα gene r |